CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Generation and functional evaluation of STAb-T cells.
Generation and functional evaluation of STAb-T cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
STAb-T疗法是一种新兴的癌症免疫治疗策略,结合了过继性细胞疗法和双特异性抗体的优势。STAb(分泌T细胞衔接器双特异性抗体)T细胞是经过基因工程改造的T淋巴细胞,能够分泌双特异性T细胞衔接器(TCE),将T细胞募集到肿瘤细胞处进行靶向杀伤。STAb-T细胞的过继转移已在临床前模型中展现出强效抗肿瘤活性,即将在人类患者中开展评估。在此,我们提供全面的指南,涵盖STAb-T细胞的制备及其在体外和血液恶性肿瘤相关体内模型中的功能与疗效评估。
STAb-T therapy is an emerging cancer immunotherapy strategy that combines the advantages of adoptive cell therapies and bispecific antibodies. STAb (Secreting T cell engager bispecific Antibodies) T cells are T lymphocytes genetically engineered to secrete bispecific T cell engagers (TCEs) that recruit T cells to target and destroy tumor cells. Adoptive transfer of STAb-T cells has demonstrated potent anti-tumor activity in preclinical models and evaluation in human patients is forthcoming.
Here, we provide comprehensive guidelines for generating STAb-T cells and assessing their functionality and efficacy in vitro and in relevant in vivo models of hematological malignancies.
MEMBER ACCOUNT
登录成功会直接打开下一页。